Philippe Creach
About Philippe Creach
MEDICAL DOCTOR (M.D.)
Specialized in dermatology, sexually transmitted disease and tropical skin disease
Master in Public Health
Degree in « Clinical and Economic Analysis of Medical Decision Making »
Role(s) / Profession(s)
Organization
- The Global Fund to Fight AIDS, Tuberculosis and Malaria
Work Location(s)
- Switzerland
Language(s)
- English
- French
- Russian
Philippe's Communities
Recent Contributions
-
Philippe Creach replied to "Expert Panel Dec. 10-14: Scaling-up GeneXpert MTB/RIF" in the MDR-TB Treatment & Prevention community.
What do we mean by the full DST as testing reliability is not the same for all drugs ?
-
Philippe Creach replied to "Expert Panel Feb. 20-24: Management of Second Line anti-TB Drugs: Getting it right" in the MDR-TB Treatment & Prevention community.
Dear All, This was the meaning of my message: as long as we continue with an inefficient system, all steps of this system, whatever well undertaken it is, will lead to failure. The point is not to improve these steps but to change the system. The failure came exactly from ...
-
Philippe Creach replied to "Expert Panel Feb. 20-24: Management of Second Line anti-TB Drugs: Getting it right" in the MDR-TB Treatment & Prevention community.
Dear Salem, I hope that you are not dreaming since an average lead time of 6 months to deliver SLD is, somehow, astonishing. I can not imagine, in any private company, such a lead time for a product much in demand and need. If I would go to a private ...
-
Philippe Creach replied to "Expert Panel Feb. 20-24: Management of Second Line anti-TB Drugs: Getting it right" in the MDR-TB Treatment & Prevention community.
Dear All, Did you consider regional procurement of SLD ? Balkans, Southern Caucasus, Central Asia... ? Best wishes, Philippe Creac'h
-
Philippe Creach replied to "Ceiling fans for use with UVGI - how slow is slow?" in the TB Infection Control community.
Dear All, Before giving consideration to any engineering measures and discussing their (relative) efficacy at length in details not always understandable, I would imagine that ensuring proper separation of patients is the must and funds should be dedicated to it at the first place. UVGI appears somehow as damage control ...
Recent Recommendations
- None at this time.